Is IOSP a good stock to buy right now?

Based on our 6-factor quantitative model, INNOSPEC INC. (IOSP) receives a "Hold" rating with a composite score of 48.1/100. It is ranked #1,741 out of 4,446 stocks. Key factor scores: Quality 50/100, Value 66/100, Momentum 33/100. The timing signal is "Neutral". This is quantitative analysis only — not investment advice.

What is the stock rating for IOSP?

INNOSPEC INC. (IOSP) has a "Hold" rating and 3-star score. The composite score of 48.1 ranks it #1,741 among 4,446 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

What sector is IOSP in?

INNOSPEC INC. operates in the Materials sector (Chemicals industry) with a market cap of $1.83 billion. It is classified as a small-cap stock.

Does IOSP pay a dividend?

Yes, IOSP pays a dividend with a current yield of 2.11%. The Materials sector average yield is 0.49%. For every $1,000 invested, you would receive approximately $21.10 in annual dividend income.

What is IOSP's P/E ratio?

IOSP has a trailing P/E ratio of 17.68x. The Materials sector average is 26.5x. This P/E is in a moderate range relative to the broader market.

How profitable is IOSP?

IOSP's quality factor score is 50/100. Gross margin: 27.7%. ROE: 7.7% vs sector average 3.3%. Margins are moderate to low, reflecting competitive market dynamics.

How is IOSP valued compared to peers?

IOSP's value factor score is 66/100 (higher = cheaper). Key multiples: P/E 17.7x, EV/EBITDA 14.1x. The stock appears attractively valued versus peers.

What is IOSP's debt level?

IOSP's debt-to-equity ratio is 37%. Sector average: 41%. Low leverage suggests conservative financial management.

IOSP has a beta of 0.74, meaning it is less volatile than the market. Stability score: 77/100.

Does IOSP have high short interest?

IOSP's short interest factor score is 40/100 (higher = less short selling). Elevated short interest may indicate bearish sentiment or short squeeze potential.

IOSP Stock Analysis: Top Small-Cap Hold (Score 48.1/100) | Blank Capital Research

Data Series	1D	5D	1M	YTD	1Y	3Y	5Y	10Y
IOSP	-0.22%	+2.53%	+7.17%	-1.15%	-12.55%	-	-	-
Industry Proxy XLB	+0.56%	+3.07%	+4.17%	+14.58%	-33.54%	-	-	-
U.S. Market SPY	-0.07%	+3.60%	+0.34%	-0.36%	+29.52%	-	-	-
Alpha vs Market	-0.16%	-1.07%	+6.83%	-0.79%	-42.08%	-	-	-
Alpha vs Sector	-0.79%	-0.54%	+3.00%	-15.73%	+20.99%	-	-	-

Metric	IOSP	Benchmark
P/E Ratio	17.7x	-33%
EV/EBITDA	14.1x	+135%
Price / Book	1.4x

Stock Entity	Score▼	Quality	Value	Momentum	P/E Ratio	ROE	Gross Margin	Net Margin	Rev Growth	D/E Ratio	Market Cap	Compare
CF CF Industries Holdings, Inc.	57	50	72	66	11.8x	21.1%	36.2%	24.9%	5.5%	41.0x	$19.7B	VS
NTR Nutrien Ltd.	57	37	70	64	54.2x	11.5%	29.0%	2.7%	-	52.0x	$35.9B	VS
UAN CVR PARTNERS, LP	56	50	71	67	12.0x	42.4%	28.5%	17.8%	23.1%	265.0x	$1.3B	VS
LXU LSB INDUSTRIES, INC.	54	50	54	73	41.2x	-3.3%	8.6%	-4.5%	11.0%	85.0x	$1.1B	VS
AA Alcoa Corp	54	50	61	71	18.7x	16.6%	10.0%	8.0%	3.1%	40.0x	$19.0B	VS
MEOH METHANEX CORP	53	34	76	72	24.6x	47.8%	19.1%	6.7%	-	149.0x	$4.6B	VS
NGVT Ingevity Corp	53	50	68	66	53.4x	-638.7%	38.1%	-12.1%	-14.7%	5,459.0x	$2.5B	VS
SEE SEALED AIR CORP/DE	52	50	67	59	11.2x	44.7%	30.2%	10.4%	0.5%	318.0x	$6.2B	VS
ACU ACME UNITED CORP	51	50	71	51	16.4x	9.0%	39.4%	5.2%	-11.5%	45.0x	$171M	VS
APD Air Products & Chemicals, Inc.	51	50	49	50	179.2x	2.4%	31.6%	2.2%	3.9%	114.0x	$64.4B	VS
IOSP INNOSPEC INC.	48	50	66	33	17.7x	7.7%	27.7%	5.8%	1.6%	37.0x	$1.8B

Key Ratio	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Gross Margin %	0.3%	0.3%	0.3%	0.3%	0.3%	0.3%	0.3%	0.3%	0.3%	0.3%	0.4%
Operating Margin %	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.0%	0.1%	0.1%	0.1%	0.1%
EBITDA Margin %	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.2%
Net Margin %	0.1%	0.1%	0.0%	0.1%	0.1%	0.1%	0.0%	0.1%	0.1%	0.0%	0.1%
FCF Margin %	-4.6%	-	-	-	-	-	9.7%	8.6%	5.1%	4.2%	10.1%
ROE %	0.1%	0.1%	0.0%	0.1%	0.1%	0.1%	0.0%	0.1%	0.1%	0.1%	0.1%
ROA %	0.1%	0.1%	0.0%	0.1%	0.1%	0.1%	0.0%	0.1%	0.1%	0.0%	0.1%
ROIC %	9.5%	7.7%	11.6%	11.1%	14.2%	10.1%	3.1%	13.1%	11.6%	14.0%	10.1%

Key Ratio

TTM

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

Gross Margin %

0.3%

0.4%

Operating Margin %

0.1%

0.0%

0.1%

EBITDA Margin %

0.1%

0.2%

Net Margin %

0.1%

0.0%

0.1%

0.0%

0.1%

0.0%

0.1%

FCF Margin %

-4.6%

9.7%

8.6%

5.1%

4.2%

10.1%

ROE %

0.1%

0.0%

0.1%

0.0%

0.1%

ROA %

0.1%

0.0%

0.1%

0.0%

0.1%

0.0%

0.1%

ROIC %

9.5%

7.7%

11.6%

11.1%

14.2%

10.1%

3.1%

13.1%

11.6%

14.0%

10.1%

Line Item	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
	$1.8B	$1.8B	$1.8B	$1.9B	$2.0B	$1.5B	$1.2B	$1.5B	$1.5B	$1.3B	$883M	$1.0B
	—	$1.3B	$1.3B	$1.4B	$1.4B	$1.0B	—	—	—	—	—	—
	$489M	$492M	$543M	$591M	$587M	$435M	$343M	$466M	$435M	$403M	$332M	$346M
Gross Margin	27.7%	27.7%	29.4%	30.3%	29.9%	29.3%	28.7%	30.8%	29.4%	30.9%	37.6%	34.2%
	—	$285M	$314M	$388M	$361M	$267M	—	—	—	—	—	—
Research & Development	—	$51M	$48M	$42M	$39M	$37M	$31M	$35M	$33M	$31M	$25M	$25M
Depreciation	—	—	—	—	—	—	$46M	$48M	$50M	$50M	$38M	$35M
Total Operating Expenses	—	$363M	$365M	$430M	$399M	$303M	—	—	—	—	—	—
	$128M	$130M	$178M	$162M	$187M	$132M	$34M	$150M	$134M	$125M	$105M	$156M
EBIT	$128M	$130M	$178M	$162M	$187M	$132M	$34M	$150M	$134M	$125M	$105M	$156M
EBITDA	$128M	$130M	$178M	$162M	$187M	$132M	$88M	$203M	$188M	$187M	$144M	$192M
Operating Margin	7.3%	7.3%	9.6%	8.3%	9.5%	8.9%	2.8%	9.9%	9.0%	9.6%	11.1%	15.4%
EBITDA Margin	7.3%	7.3%	9.6%	8.3%	9.5%	8.9%	7.3%	13.4%	12.7%	14.3%	16.3%	18.9%
	—	$138M	$41M	$174M	$185M	$134M	—	—	—	—	—	—
Income Tax Expense	—	$22M	$6M	$35M	$52M	$41M	$11M	$38M	$47M	$66M	$22M	$33M
	$103M	$117M	$36M	$139M	$133M	$93M	$29M	$112M	$85M	$62M	$81M	$120M
Net Margin	5.8%	6.6%	1.9%	7.1%	6.8%	6.3%	2.4%	7.4%	5.8%	4.7%	9.2%	11.8%
	$4.69	$4.69	$1.43	$5.60	$5.37	$3.78	$1.17	$4.58	$3.48	$2.56	$3.39	$4.96
Diluted EPS	$4.69	$4.67	$1.42	$5.56	$5.32	$3.75	$1.17	$4.58	$3.48	$2.56	$3.39	$4.96
Weighted Avg Basic	—	25M	25M	25M	25M	25M	—	—	—	—	—	—
Weighted Avg Diluted	—	25M	25M	25M	25M	25M	—	—	—	—	—	—

Line Item

TTM

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

$1.8B

$1.9B

$2.0B

$1.5B

$1.2B

$1.5B

$1.3B

$883M

$1.0B

—

$1.3B

$1.4B

$1.0B

—

$489M

$492M

$543M

$591M

$587M

$435M

$343M

$466M

$435M

$403M

$332M

$346M

Gross Margin

27.7%

29.4%

30.3%

29.9%

29.3%

28.7%

30.8%

29.4%

30.9%

37.6%

34.2%

—

$285M

$314M

$388M

$361M

$267M

—

Research & Development

—

$51M

$48M

$42M

$39M

$37M

$31M

$35M

$33M

$31M

$25M

Depreciation

—

$46M

$48M

$50M

$38M

$35M

Total Operating Expenses

—

$363M

$365M

$430M

$399M

$303M

—

$128M

$130M

$178M

$162M

$187M

$132M

$34M

$150M

$134M

$125M

$105M

$156M

EBIT

$128M

$130M

$178M

$162M

$187M

$132M

$34M

$150M

$134M

$125M

$105M

$156M

EBITDA

$128M

$130M

$178M

$162M

$187M

$132M

$88M

$203M

$188M

$187M

$144M

$192M

Operating Margin

7.3%

9.6%

8.3%

9.5%

8.9%

2.8%

9.9%

9.0%

9.6%

11.1%

15.4%

EBITDA Margin

7.3%

9.6%

8.3%

9.5%

8.9%

7.3%

13.4%

12.7%

14.3%

16.3%

18.9%

—

$138M

$41M

$174M

$185M

$134M

—

Income Tax Expense

—

$22M

$6M

$35M

$52M

$41M

$11M

$38M

$47M

$66M

$22M

$33M

$103M

$117M

$36M

$139M

$133M

$93M

$29M

$112M

$85M

$62M

$81M

$120M

Net Margin

5.8%

6.6%

1.9%

7.1%

6.8%

6.3%

2.4%

7.4%

5.8%

4.7%

9.2%

11.8%

$4.69

$1.43

$5.60

$5.37

$3.78

$1.17

$4.58

$3.48

$2.56

$3.39

$4.96

Diluted EPS

$4.69

$4.67

$1.42

$5.56

$5.32

$3.75

$1.17

$4.58

$3.48

$2.56

$3.39

$4.96

Weighted Avg Basic

—

25M

—

Weighted Avg Diluted

—

25M

—

INNOSPEC INC. (IOSP) Stock Analysis — April 2026 Rating, Price, and Forecast

Last updated: April 2026

Company Overview — What Does INNOSPEC INC. Do?

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. INNOSPEC INC. (IOSP) is classified as a small-cap stock in the Materials sector, specifically within the Chemicals industry. The company is led by CEO Patrick S. Williams and employs approximately 2,100 people, headquartered in ENGLEWOOD, Colorado. With a market capitalization of $1.8B, IOSP is one of the notable companies in the Materials sector.

INNOSPEC INC. (IOSP) Stock Rating — Hold (April 2026)

As of April 2026, INNOSPEC INC. receives a Hold rating with a composite score of 48.1/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.IOSP ranks #1,741 out of 4,446 stocks in our coverage universe. Within the Materials sector, INNOSPEC INC. ranks #114 of 284 stocks, placing it in the upper half of its Materials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

IOSP Stock Price and 52-Week Range

INNOSPEC INC. (IOSP) currently trades at $75.66. The stock lost $0.17 (0.2%) in the most recent trading session. The 52-week high for IOSP is $99.48, which means the stock is currently trading -23.9% from its annual peak. The 52-week low is $67.29, putting the stock 12.4% above its annual trough. Recent trading volume was 128K shares, suggesting relatively thin trading activity.

Is IOSP Overvalued or Undervalued? — Valuation Analysis

INNOSPEC INC. (IOSP) carries a value factor score of 66/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 17.68x, compared to the Materials sector average of 26.50x — a discount of 33%. The price-to-book ratio stands at 1.36x, versus the sector average of 2.83x. The price-to-sales ratio is 1.03x, compared to 0.74x for the average Materials stock. On an enterprise value basis, IOSP trades at 14.14x EV/EBITDA, versus 6.01x for the sector.

Overall, IOSP's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.

INNOSPEC INC. Profitability — ROE, Margins, and Quality Score

INNOSPEC INC. (IOSP) earns a quality factor score of 50/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is 7.7%, compared to the Materials sector average of 3.3%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at 5.6% versus the sector average of 0.6%.

On a margin basis, INNOSPEC INC. reports gross margins of 27.7%, compared to 29.8% for the sector. The operating margin is 7.3% (sector: 6.0%). Net profit margin stands at 5.8%, versus 3.0% for the average Materials stock. Revenue growth is running at 1.6% on a trailing basis, compared to 1.8% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.

IOSP Debt, Balance Sheet, and Financial Health

INNOSPEC INC. has a debt-to-equity ratio of 37.0%, compared to the Materials sector average of 41.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 2.79x, indicating strong short-term liquidity. Total debt on the balance sheet is $0. Cash and equivalents stand at $271M.

IOSP has a beta of 0.74, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for INNOSPEC INC. is 77/100, indicating low-volatility characteristics and consistent price behavior that appeals to risk-averse investors.

INNOSPEC INC. Revenue and Earnings History — Quarterly Trend

In TTM 2026, INNOSPEC INC. reported revenue of $1.77B and earnings per share (EPS) of $4.69. Net income for the quarter was $103M. Gross margin was 27.7%. Operating income came in at $128M.

In FY 2025, INNOSPEC INC. reported revenue of $1.78B and earnings per share (EPS) of $4.69. Net income for the quarter was $117M. Gross margin was 27.7%. Revenue grew -3.7% year-over-year compared to FY 2024. Operating income came in at $130M.

In Q3 2025, INNOSPEC INC. reported revenue of $442M and earnings per share (EPS) of $0.52. Net income for the quarter was $13M. Gross margin was 26.4%. Revenue grew -0.3% year-over-year compared to Q3 2024. Operating income came in at $6M.

In Q2 2025, INNOSPEC INC. reported revenue of $440M and earnings per share (EPS) of $0.94. Net income for the quarter was $24M. Gross margin was 28.0%. Revenue grew 1.1% year-over-year compared to Q2 2024. Operating income came in at $34M.

Over the past 8 quarters, INNOSPEC INC. has demonstrated a growth trajectory, with revenue expanding from $435M to $1.77B. Investors analyzing IOSP stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

IOSP Dividend Yield and Income Analysis

INNOSPEC INC. (IOSP) currently pays a dividend yield of 2.1%. At this yield, a $10,000 investment in IOSP stock would generate approximately $$211.00 in annual dividend income. This compares to the Materials sector average dividend yield of 0.5%, meaning IOSP offers above-average income for its sector. The net margin of 5.8% provides reasonable coverage for the dividend, though investors should monitor payout sustainability.

IOSP Momentum and Technical Analysis Profile

INNOSPEC INC. (IOSP) has a momentum factor score of 33/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 33/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 40/100 reflects moderate short selling activity.

IOSP vs Competitors — Materials Sector Ranking and Peer Comparison

Within the Materials sector, INNOSPEC INC. (IOSP) ranks #114 out of 284 stocks based on the Blank Capital composite score. This places IOSP in the upper half of all Materials stocks in our coverage universe. Key competitors and sector peers include CF Industries Holdings, Inc. (CF) with a score of 56.6/100, Nutrien Ltd. (NTR) with a score of 56.6/100, CVR PARTNERS, LP (UAN) with a score of 55.6/100, LSB INDUSTRIES, INC. (LXU) with a score of 53.6/100, and ACME UNITED CORP (ACU) with a score of 51.2/100.

Comparing IOSP against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full IOSP vs S&P 500 (SPY) comparison to assess how INNOSPEC INC. stacks up against the broader market across all factor dimensions.

IOSP Next Earnings Date

No upcoming earnings date has been announced for INNOSPEC INC. (IOSP) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy IOSP? — Investment Thesis Summary

INNOSPEC INC. presents a balanced picture with arguments on both sides. The value score of 66/100 suggests attractive pricing relative to fundamentals. Momentum is weak at 33/100, a headwind for near-term performance. Low volatility (stability score 77/100) reduces downside risk.

In summary, INNOSPEC INC. (IOSP) earns a Hold rating with a composite score of 48.1/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on IOSP stock.

Related Resources for IOSP Investors

Explore more research and tools: IOSP vs S&P 500 comparison, top Materials stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare IOSP head-to-head with peers: IOSP vs CF, IOSP vs NTR, IOSP vs UAN.

Business quality

Valuation edge

Market alpha

Unlock Investment Thesis

Unlock Performance & Technicals

Unlock Valuation Tools

Institutional peer matrix

Dispersion: efficiency vs. valuation

Lateral intelligence network

Unlock Financial Statements

Unlock Ownership & Management

Intelligence Feed

Innospec Schedules First Quarter 2026 Earnings Release and Conference Call

Innospec (IOSP) Down 21.8% Since Last Earnings Report: Can It Rebound?

Alpha Olefin Sulfonate Market worth $942.6 million by 2030 - Exclusive Report by MarketsandMarkets™

Is Innospec (IOSP) Now At An Attractive Price After Recent Share Price Slide

US Undiscovered Gems To Explore In March 2026

Unlock Earnings Transcripts

Institutional Intelligence FAQ

Related Research & Tools

Related Materials Stocks

INNOSPEC INC. (IOSP) Stock Analysis — April 2026 Rating, Price, and Forecast

Company Overview — What Does INNOSPEC INC. Do?

INNOSPEC INC. (IOSP) Stock Rating — Hold (April 2026)

IOSP Stock Price and 52-Week Range

Is IOSP Overvalued or Undervalued? — Valuation Analysis

INNOSPEC INC. Profitability — ROE, Margins, and Quality Score

IOSP Debt, Balance Sheet, and Financial Health

INNOSPEC INC. Revenue and Earnings History — Quarterly Trend

IOSP Dividend Yield and Income Analysis

IOSP Momentum and Technical Analysis Profile

IOSP vs Competitors — Materials Sector Ranking and Peer Comparison

IOSP Next Earnings Date

Should You Buy IOSP? — Investment Thesis Summary

Related Resources for IOSP Investors

Comments

Institutional Benchmarks

Get alerted on rating changes

Intelligence Feed

Innospec Schedules First Quarter 2026 Earnings Release and Conference Call

Innospec (IOSP) Down 21.8% Since Last Earnings Report: Can It Rebound?

Alpha Olefin Sulfonate Market worth $942.6 million by 2030 - Exclusive Report by MarketsandMarkets™

Is Innospec (IOSP) Now At An Attractive Price After Recent Share Price Slide

US Undiscovered Gems To Explore In March 2026